Tag: Business & Investments

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics

Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram…

ME Desk